Vidyalakshmi Sethunath

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Xiaoyong Fu, Resel Pereira, Carmine De Angelis et al. · Proceedings of the National Academy of Sciences · 2019 · 164 citations · Full text

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

Xiaowei Xu, Carmine De Angelis, Kathleen A. Burke et al. · Clinical Cancer Research · 2017 · 122 citations · Full text

Integrative clinical and molecular characterization of translocation renal cell carcinoma

Ziad Bakouny, Ananthan Sadagopan, Praful Ravi et al. · Cell Reports · 2022 · 110 citations · Full text

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo et al. · Clinical Cancer Research · 2021 · 91 citations · Full text

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

Carmine De Angelis, Chandandeep Nagi, Cliff C. Hoyt et al. · Clinical Cancer Research · 2019 · 81 citations · Full text